Bank of Montreal
ALGS icon

Bank of Montreal’s Aligos Therapeutics ALGS Stock Holding History

Bank of Montreal’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13
Closed -$7K – 3666
2021
Q1 		$7K Sell
13
-50
-79% -$33.3K ﹤0.01% 4500
2020
Q4 		$49K Buy
+63
New +$30.7K ﹤0.01% 3946

Other funds holding ALGS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of Montreal's ALGS Position: Q2 2021 in Review

Bank of Montreal sold out of Aligos Therapeutics (ALGS) in Q2 2021, closing a stake of 13 shares — an estimated $7K sold.

Bank of Montreal first reported a position in ALGS in Q4 2020 and held it in 2 quarters. The position peaked at $49K in Q4 2020. 57 funds tracked by Wall St. Rank hold ALGS as of Q2 2021.

  • Bank of Montreal reported no remaining Aligos Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 13 Aligos Therapeutics shares in Q2 2021, an estimated $7K.
  • Bank of Montreal first reported a position in Aligos Therapeutics in Q4 2020 and held it in 2 quarters.
  • Bank of Montreal's Aligos Therapeutics position peaked at $49K in Q4 2020.
  • 57 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.